This article in Corporate Disputes highlights a recent roundtable discussion featuring Group Vice President and Life Sciences Practice Leader Greg Bell and his thoughts on trends in intellectual property and the impact of high-profile IP infringement cases on the life sciences landscape more broadly.
Investment treaty disputes in the life sciences industry
In its global scale and economic impact, the life sciences industry presents unique considerations for investment treaty arbitrations. Recently, the COVID-19...